Delivery Order SPE2DR25D1017-SPE2DR26F9DHH
- Not listed
- The Defense Logistics Agency awarded a $3,486.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector on January 7, 2026, with completion scheduled for January 29, 2026. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the primary vehicle for supplying pharmaceutical products and medical...
- The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, competitively awarded contract with an ultimate completion date of December 16, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,486.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on January 13, 2026. This firm fixed-price delivery order, with an ultimate completion date of February 4, 2026, was competitively awarded without set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under...
- The Defense Logistics Agency awarded a $3,082.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of November 10, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 9, 2025, with completion expected by December 31, 2025. This competitively awarded, firm fixed-price delivery order requires performance at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $9,745.98 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed-price contract with an ultimate completion date of January 21, 2026, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on November 13, 2025, with an ultimate completion date of December 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters location. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector units. This firm fixed-price delivery order, issued on December 5, 2025, with completion targeted for December 29, 2025, represents a non-competitive set-aside award. The product will be delivered to the performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,330.68 for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 9, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9DHHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,973.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on January 15, 2026, with an ultimate completion date of February 6, 2026. This firm fixed-price, competitively awarded delivery order was issued without a set-aside designation and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order supports the Defense Logistics Agency's mission to supply critical pharmaceutical products to military healthcare systems worldwide. Benlysta (belimumab) is a biologic immunosuppressant used in the treatment of systemic lupus erythematosus, reflecting the medical supply chain's need to maintain diverse therapeutic medications for service members and military beneficiaries. As a major pharmaceutical distributor with extensive federal contracting experience, AmerisourceBergen/Cencora regularly fulfills similar task orders for specialty medications, generics, and medical devices across multiple therapeutic domains through its comprehensive IDC vehicle with DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 1/14/26 |